This conserved lipid acyltransferase has many re-entrant segments but only one true TM helix. Most closely related to bacterial acyltransferases.. Heavily expanded in kinetoplastids for unknown reasons. Localization: ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 45 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 34 |
NetGPI | no | yes: 0, no: 34 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 28 |
GO:0110165 | cellular anatomical entity | 1 | 28 |
Related structures:
AlphaFold database: E9AE89
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 6 |
GO:0006644 | phospholipid metabolic process | 4 | 6 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 6 |
GO:0006654 | phosphatidic acid biosynthetic process | 6 | 6 |
GO:0006793 | phosphorus metabolic process | 3 | 6 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 6 |
GO:0008152 | metabolic process | 1 | 6 |
GO:0008610 | lipid biosynthetic process | 4 | 6 |
GO:0008654 | phospholipid biosynthetic process | 5 | 6 |
GO:0009058 | biosynthetic process | 2 | 6 |
GO:0009987 | cellular process | 1 | 6 |
GO:0019637 | organophosphate metabolic process | 3 | 6 |
GO:0044237 | cellular metabolic process | 2 | 6 |
GO:0044238 | primary metabolic process | 2 | 6 |
GO:0044249 | cellular biosynthetic process | 3 | 6 |
GO:0044255 | cellular lipid metabolic process | 3 | 6 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 6 |
GO:0046473 | phosphatidic acid metabolic process | 6 | 6 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 6 |
GO:0046486 | glycerolipid metabolic process | 4 | 6 |
GO:0071704 | organic substance metabolic process | 2 | 6 |
GO:0090407 | organophosphate biosynthetic process | 4 | 6 |
GO:1901576 | organic substance biosynthetic process | 3 | 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 35 |
GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 7 | 10 |
GO:0008374 | O-acyltransferase activity | 5 | 10 |
GO:0016411 | acylglycerol O-acyltransferase activity | 6 | 10 |
GO:0016740 | transferase activity | 2 | 35 |
GO:0016746 | acyltransferase activity | 3 | 35 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 10 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 10 |
GO:0071617 | lysophospholipid acyltransferase activity | 5 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 265 | 269 | PF00656 | 0.267 |
CLV_NRD_NRD_1 | 313 | 315 | PF00675 | 0.746 |
CLV_PCSK_FUR_1 | 311 | 315 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 292 | 294 | PF00082 | 0.596 |
CLV_PCSK_KEX2_1 | 313 | 315 | PF00082 | 0.784 |
CLV_PCSK_PC1ET2_1 | 292 | 294 | PF00082 | 0.599 |
CLV_PCSK_SKI1_1 | 135 | 139 | PF00082 | 0.501 |
CLV_PCSK_SKI1_1 | 218 | 222 | PF00082 | 0.493 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.235 |
DOC_CYCLIN_RxL_1 | 189 | 199 | PF00134 | 0.220 |
DOC_MAPK_HePTP_8 | 28 | 40 | PF00069 | 0.453 |
DOC_MAPK_MEF2A_6 | 139 | 147 | PF00069 | 0.302 |
DOC_MAPK_MEF2A_6 | 31 | 40 | PF00069 | 0.445 |
DOC_PP1_RVXF_1 | 190 | 197 | PF00149 | 0.333 |
DOC_PP1_RVXF_1 | 29 | 35 | PF00149 | 0.476 |
DOC_PP1_RVXF_1 | 48 | 55 | PF00149 | 0.209 |
DOC_PP1_RVXF_1 | 73 | 80 | PF00149 | 0.315 |
DOC_PP2B_LxvP_1 | 143 | 146 | PF13499 | 0.329 |
DOC_PP4_FxxP_1 | 116 | 119 | PF00568 | 0.298 |
DOC_USP7_MATH_1 | 108 | 112 | PF00917 | 0.302 |
DOC_WW_Pin1_4 | 202 | 207 | PF00397 | 0.267 |
LIG_14-3-3_CanoR_1 | 23 | 28 | PF00244 | 0.532 |
LIG_14-3-3_CanoR_1 | 31 | 37 | PF00244 | 0.475 |
LIG_14-3-3_CanoR_1 | 50 | 55 | PF00244 | 0.260 |
LIG_Actin_WH2_2 | 123 | 141 | PF00022 | 0.365 |
LIG_AP2alpha_1 | 116 | 120 | PF02296 | 0.247 |
LIG_AP2alpha_2 | 118 | 120 | PF02296 | 0.327 |
LIG_BRCT_BRCA1_1 | 166 | 170 | PF00533 | 0.310 |
LIG_BRCT_BRCA1_1 | 192 | 196 | PF00533 | 0.335 |
LIG_CSL_BTD_1 | 238 | 241 | PF09270 | 0.361 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.323 |
LIG_FHA_1 | 203 | 209 | PF00498 | 0.310 |
LIG_FHA_1 | 56 | 62 | PF00498 | 0.334 |
LIG_GBD_Chelix_1 | 272 | 280 | PF00786 | 0.536 |
LIG_Integrin_isoDGR_2 | 133 | 135 | PF01839 | 0.389 |
LIG_LIR_Apic_2 | 115 | 119 | PF02991 | 0.175 |
LIG_LIR_Gen_1 | 252 | 262 | PF02991 | 0.359 |
LIG_LIR_Gen_1 | 98 | 109 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 115 | 120 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 216 | 220 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 252 | 257 | PF02991 | 0.341 |
LIG_LIR_Nem_3 | 53 | 57 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 7 | 12 | PF02991 | 0.465 |
LIG_NRBOX | 1 | 7 | PF00104 | 0.273 |
LIG_NRBOX | 24 | 30 | PF00104 | 0.626 |
LIG_Pex14_2 | 116 | 120 | PF04695 | 0.254 |
LIG_Pex14_2 | 158 | 162 | PF04695 | 0.289 |
LIG_Pex14_2 | 79 | 83 | PF04695 | 0.344 |
LIG_SH2_PTP2 | 254 | 257 | PF00017 | 0.373 |
LIG_SH2_SRC | 254 | 257 | PF00017 | 0.336 |
LIG_SH2_STAP1 | 128 | 132 | PF00017 | 0.302 |
LIG_SH2_STAP1 | 57 | 61 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.257 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.291 |
LIG_SH2_STAT5 | 254 | 257 | PF00017 | 0.315 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.354 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.336 |
LIG_SH3_1 | 244 | 250 | PF00018 | 0.335 |
LIG_SH3_3 | 235 | 241 | PF00018 | 0.294 |
LIG_SH3_3 | 244 | 250 | PF00018 | 0.310 |
LIG_SH3_3 | 5 | 11 | PF00018 | 0.481 |
LIG_SH3_3 | 90 | 96 | PF00018 | 0.391 |
LIG_SUMO_SIM_anti_2 | 26 | 31 | PF11976 | 0.523 |
LIG_SUMO_SIM_par_1 | 1 | 7 | PF11976 | 0.194 |
LIG_TYR_ITIM | 126 | 131 | PF00017 | 0.316 |
LIG_WRC_WIRS_1 | 214 | 219 | PF05994 | 0.281 |
LIG_WRC_WIRS_1 | 51 | 56 | PF05994 | 0.318 |
MOD_CK1_1 | 216 | 222 | PF00069 | 0.301 |
MOD_Cter_Amidation | 290 | 293 | PF01082 | 0.597 |
MOD_Cter_Amidation | 311 | 314 | PF01082 | 0.793 |
MOD_GlcNHglycan | 164 | 169 | PF01048 | 0.571 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.571 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.283 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.270 |
MOD_GSK3_1 | 95 | 102 | PF00069 | 0.354 |
MOD_LATS_1 | 21 | 27 | PF00433 | 0.431 |
MOD_N-GLC_1 | 202 | 207 | PF02516 | 0.467 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.265 |
MOD_NEK2_1 | 138 | 143 | PF00069 | 0.306 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.387 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.407 |
MOD_NEK2_2 | 108 | 113 | PF00069 | 0.282 |
MOD_PK_1 | 23 | 29 | PF00069 | 0.432 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.270 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.276 |
MOD_Plk_4 | 138 | 144 | PF00069 | 0.253 |
MOD_Plk_4 | 216 | 222 | PF00069 | 0.314 |
MOD_Plk_4 | 23 | 29 | PF00069 | 0.567 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.477 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.340 |
MOD_ProDKin_1 | 202 | 208 | PF00069 | 0.267 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.330 |
TRG_ENDOCYTIC_2 | 128 | 131 | PF00928 | 0.338 |
TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 228 | 231 | PF00928 | 0.273 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.330 |
TRG_ER_diArg_1 | 311 | 314 | PF00400 | 0.574 |
TRG_Pf-PMV_PEXEL_1 | 282 | 286 | PF00026 | 0.587 |
TRG_Pf-PMV_PEXEL_1 | 314 | 318 | PF00026 | 0.767 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P455 | Leptomonas seymouri | 37% | 93% |
A0A0N0P6B0 | Leptomonas seymouri | 24% | 100% |
A0A0N1HTP4 | Leptomonas seymouri | 31% | 100% |
A0A0N1I6V1 | Leptomonas seymouri | 58% | 100% |
A0A0N1IKX5 | Leptomonas seymouri | 52% | 100% |
A0A0S4IQ05 | Bodo saltans | 38% | 94% |
A0A0S4IR22 | Bodo saltans | 34% | 100% |
A0A0S4JRB2 | Bodo saltans | 33% | 100% |
A0A0S4JRP7 | Bodo saltans | 21% | 100% |
A0A1X0P9F0 | Trypanosomatidae | 40% | 100% |
A0A3Q8IFY7 | Leishmania donovani | 24% | 100% |
A0A3R7NKA0 | Trypanosoma rangeli | 42% | 100% |
A0A3S5H5E4 | Leishmania donovani | 31% | 74% |
A0A3S5H7L8 | Leishmania donovani | 60% | 98% |
A0A3S7WNW6 | Leishmania donovani | 32% | 89% |
A4H418 | Leishmania braziliensis | 35% | 100% |
A4H419 | Leishmania braziliensis | 32% | 94% |
A4HHM7 | Leishmania braziliensis | 50% | 100% |
A4HKI5 | Leishmania braziliensis | 23% | 100% |
A4HSA1 | Leishmania infantum | 31% | 100% |
A4HSA2 | Leishmania infantum | 32% | 89% |
A4I4U1 | Leishmania infantum | 92% | 98% |
A4I4U2 | Leishmania infantum | 59% | 100% |
A4I816 | Leishmania infantum | 24% | 100% |
C9ZLI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9AE90 | Leishmania major | 61% | 100% |
E9AK86 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
E9ALJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 53% | 100% |
E9B2X4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
Q4Q582 | Leishmania major | 23% | 100% |
Q9NF90 | Leishmania major | 33% | 89% |
Q9NF91 | Leishmania major | 30% | 83% |
V5C201 | Trypanosoma cruzi | 40% | 100% |